Dallah Healthcare Company

Equities

4004

SA135G51UI10

Healthcare Facilities & Services

End-of-day quote Saudi Arabian S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
163.2 ^SAR	-1.33%		-3.89%	-5.01%

Mar. 20	Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 14	Dallah Healthcare Logs Higher FY23 Net Profit, Revenue	MT

Dallah Healthcare Company Reports Earnings Results for the Second Quarter Ended June 30, 2021

August 11, 2021 at 03:15 am EDT

Dallah Healthcare Company announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was SAR 490.826 million compared to SAR 247.560 million a year ago. Net income was SAR 50.336 million compared to SAR 6.993 million a year ago.

Latest news about Dallah Healthcare Company

Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
Dallah Healthcare Logs Higher FY23 Net Profit, Revenue	Mar. 14	MT
Ayyan Investment Appoints Financial Adviser for Share Exchange Deal with Dallah Healthcare	Mar. 05	MT
Dallah Healthcare Company signed of a non-binding memorandum agreement to acquire 97% stake in Al-Ahsa Medical Services Company and 100% stake in Al-Salam Medical Services Company from Ayyan Investment Company.	Feb. 25	CI
Dallah Healthcare Co. Announces the Distribution of Cash Dividends for the Fourth Quarter of 2023, Payable on 30 January 2024	Dec. 25	CI
Dallah Healthcare Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Dallah Healthcare Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-13	CI
Dallah Healthcare Company Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-23	CI
Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-21	CI
Dallah Healthcare Company completed the acquisition of an additional 18.98% stake in International Medical Centre.	23-01-15	CI
Dallah Healthcare Co. Announces the Distribution of Cash Dividends for Second Half of the Fiscal Year 2022, Payable on December 29, 2022	22-12-19	CI
Dallah Healthcare Company Approves Resignation of Fahad Bin Abdulaziz Al-Rabiah as Board of Directors and Compensation and Remuneration Committee	22-11-15	CI
Dallah Healthcare Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
Dallah Healthcare Company Approves Board Appointments	22-11-02	CI
Dallah Healthcare Co. Announces the Distribution of Cash Dividends for First Half of 2022	22-09-21	CI
Dallah Healthcare Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-18	CI
Dallah Healthcare Company Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-19	CI
Dallah Healthcare Company Receives Ministry of Health's Approval to Increase the Operational Capacity of Dallah Namar Hospital by 150 Additional Beds	22-04-24	CI
Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-24	CI
Dallah Healthcare Company signed of a non-binding memorandum of understanding to acquire an additional 18.98% stake in International Medical Centre.	22-01-24	CI
Dallah Healthcare Company Reports Earnings Results for the Third Quarter Ended September 30, 2021	21-11-07	CI
Dallah Healthcare Company signed an agreement to acquire a 8.2% stake in International Medical Centre from Abdulaziz Mohammed Al Meshaal and Abeer Mohammed Al Meashaal for approximately SAR 290 million.	21-10-26	CI
Dallah Healthcare to Seek Acquisition	21-10-24	CI
Dallah Healthcare Co. Announces the Distribution of Cash Dividends for First Half of 2021	21-09-22	CI
Dallah Healthcare Company Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-11	CI

Chart Dallah Healthcare Company

Duration

Period

More charts

Company Profile

Dallah Healthcare Company SJSC, formerly Dallah Healthcare Co, is a Saudi Arabia-based company engaged in the provision and operation of healthcare programs and utilities. The Company operates in the following business segments: Hospitals; Medicines, and Head Office. The Hospitalsâ segment objectives are to own, manage, operate and maintain healthcare facilities. The Medicinesâ segment objectives are to import, distribute, wholesale and retail medicines, as well as manufacture medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging materials. The Head Officeâs segment objectives are to operate, manage and maintain healthcare facilities; wholesale and retail surgical equipment, artificial parts, handicapped and hospitals equipment, as well as other supporting services.

Sector

Healthcare Facilities & Services

Calendar

2024-04-28 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Dallah Healthcare Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

163.2 SAR

Average target price

154.4 SAR

Spread / Average Target

-5.40%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

	1st Jan change	Capi.
DALLAH HEALTHCARE COMPANY	-5.01%	4.25B
AIER EYE HOSPITAL GROUP CO., LTD.	-20.16%	16.21B
BANGKOK DUSIT MEDICAL SERVICES	+4.50%	12.44B
IHH HEALTHCARE	+3.98%	11.58B
APOLLO HOSPITALS ENTERPRISE LIMITED	+9.72%	10.79B
ENCOMPASS HEALTH CORPORATION	+23.61%	8.26B
RAMSAY HEALTH CARE LIMITED	-2.19%	7.68B
MOUWASAT MEDICAL SERVICES COMPANY	+20.75%	7.2B
THE ENSIGN GROUP, INC.	+4.49%	6.67B
GLOBAL HEALTH LIMITED	+50.89%	4.66B

Hospitals, Clinics & Primary Care Services